February 18, 2026 · Form 4 insider transaction
Atkinson Edward Morrow III sold 817 shares of Vertex Pharmaceuticals Incorporated at $473.68 per share, a transaction worth $387.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025.